HLS Therapeutics to Host Fiscal 2024 Financial Results Conference Call

About this update from Hls Therapeutics, Inc.

[{"type":"text","content":"\n\n\n\n HLS Therapeutics to Host Fiscal 2024 Financial Results Conference Call\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n TORONTO\n \n\n ,\n \n\n Feb. 27, 2025\n \n\n /CNW/ - HLS Therapeutics Inc. (\"HLS\" or the \"Company\") (TSX: HLS), announces that it will release its Q4 and fiscal 2024 financial results on\n \n Thursday, March 13, 2025\n \n . The Company will hold a conference call that same day at\n \n 8:30 a.m. ET\n \n to discuss its results. The call will be hosted by\n \n Craig Millian\n \n , Chief Executive Officer;\n \n John Hanna\n \n , Chief Financial Officer; and\n \n Brian Walsh\n \n , Chief Commercial Officer.\n \n Slides to accompany management's prepared remarks will be available to view via the webcast\n \n .\n \n\n\n CONFERENCE ID:\n \n 29035\n \n\n\n DATE:\n \n Thursday, March 13, 2025\n \n\n\n TIME:\n \n 8:30 a.m. ET\n \n\n\n WEBCAST LINK:\n \n\n\n https://app.webinar.net/rZxdqA40KDB\n \n\n\n\n\n TRADITIONAL DIAL-IN NUMBER:\n \n 1-888-699-1199 or 1-416-945-7677\n \n\n\n RAPIDCONNECT:\n \n To instantly join the conference call by phone, please use the following URL to easily register and be connected into the conference call automatically:\n \n https://emportal.ink/4fZYDLM\n \n\n\n\n TAPED REPLAY:\n \n 1-888-660-6345 or 1-646-517-4150\n \n\n\n REPLAY CODE:\n \n 29035#\n \n\n The taped replay will be available for 14 days and the archived webcast will be available for 365 days.\n \n\n A link to the live audio webcast of the conference call will also be available on the events page of the investors section of HLS Therapeutics' website at\n \n www.hlstherapeutics.com\n \n . Please connect at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be required to hear the webcast.\n \n\n\n ABOUT HLS THERAPEUTICS INC.\n \n\n Formed in 2015, HLS is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. HLS's focus...

More updates from Hls Therapeutics, Inc.